AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (November 18, 2005). doi:10.1152/ajpheart.01006.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/4/H1484    most recent
01006.2005v2
01006.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneko, K.
Right arrow Articles by Sueishi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaneko, K.
Right arrow Articles by Sueishi, K.
Submitted on September 23, 2005
Accepted on November 14, 2005

A Free Radical Scavenger But Not FGF-2-mediated Angiogenic Therapy Rescues Myonephrophathic Metabolic Syndrome in Severe Hind Limb Ischemia

Kazuhiro Kaneko1, Yonemitsu2, Takaaki Fujii2, Mitsuho Onimaru2, Chen-Hao Jin2, Makoto Inoue3, Mamoru Hasegawa3, Toshihiro Onohara4, Yoshihiko Maehara4, and Katsuo Sueishi2*

1 Department of Pathology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan; Department of Surgery and Science, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
2 Department of Pathology, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan
3 DNAVEC Corporation, Tsukuba, Japan
4 Department of Surgery and Science, Kyushu University, Graduate School of Medical Sciences, Fukuoka, Japan

* To whom correspondence should be addressed. E-mail: yonemitu{at}pathol1.med.kyushu-u.ac.jp.

The therapeutic use of angiogenic factors shows promise in the treatment of critical limb ischemia; however, its potential for myonephrophathic metabolic syndrome (MNMS), a fatal complication caused by arterial reconstruction, has not been elucidated. The objective of this study was to evaluate the effectiveness of recombinant Sendai virus-mediated gene transfer of fibroblast growth factor-2 (FGF-2) directly compared to that of a radical scavenger, MCI-186, in a rat model of MNMS. MNMS was surgically induced by aortic occlusion below renal arteries for 4 hours, followed by 6 hours of reperfusion. Administration of MCI-186 (twice; i.v. 5 min before induced ischemia and i.p. 5 min before reperfusion, 10 mg/kg, respectively), but not FGF-2 gene transfer (once, 48 hours before induced ischemia), dramatically prevented the increase of serum biochemical markers as well as the edema of the gastrocnemius muscle. The effect of MCI-186 was accompanied by the marked suppression of the neutrophilic infiltration into the local (muscle) and remote (lung) organs. Although serum and muscular levels of a neutrophil-chemoattractant (GRO/CINC-1) were not affected by any treatment, the serum level of soluble intercellular adhesion molecule-1 was decreased by treatment with MCI-186 but not by treatment with FGF-2. These results suggest the distinct mechanism of MNMS from critical limb ischemia without reperfusion. Therefore, radical scavenging should be paid more attention than therapeutic angiogenesis when arterial circulation is reconstructed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.